Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Vectibix (panitumumab) - Important Safety Information from Amgen as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
27/05/2011
Problem Or Issue:
Important Safety Information from Amgen on the association of Vectibix (panitumumab) with keratitis and ulcerative keratitis.
Important Safety Information - Vectibix
« Back
Date Printed: 30/04/2024